Risk Factors for Graft Failure with Busulfan/Fludarabine-Based Conditioning in Children Undergoing Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders

被引：0
|
作者：
Huang, Benjamin [1 ]
Dvorak, Christopher C. [2 ]
Wahlstrom, Justin [3 ]
Hwang, Jimmy [4 ]
Long-Boyle, Janel R. [3 ]
Cowan, Morton Jerome [2 ]
Horn, Biljana N. [1 ]
机构：
[1] UCSF Benioff Childrens Hosp, San Francisco, CA USA
[2] Blood & Marrow Transplant Program, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia
    Yabe, Miharu
    Sako, Masahiro
    Yabe, Hiromasa
    Osugi, Yuko
    Kurosawa, Hidemitsu
    Nara, Taemi
    Tokuyama, Mika
    Adachi, Souichi
    Kobayashi, Chie
    Yanagimachi, Masakatsu
    Ohtsuka, Yoshitoshi
    Nakazawa, Yozo
    Ogawa, Chitose
    Manabe, Atsushi
    Kojima, Seiji
    Nakahata, Tatsutoshi
    PEDIATRIC TRANSPLANTATION, 2008, 12 (08) : 862 - 867
  • [42] Risk Factors for Graft Failure and Survival after Reduced Intensity (RIC) Conditioning Allogeneic Hematopoietic Cell Transplantation (HUT) for Myelofibrosis
    Glotzbecker, Brett
    Kim, Haesook T.
    Cutler, Corey S.
    Koreth, John
    Armand, Philippe
    Nikiforow, Sarah
    Antin, Joseph H.
    Soiffer, Robert J.
    Alyea, Edwin P., III
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S34 - S34
  • [43] Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen in Patients with Wiskott-Aldrich Syndrome Given Allogeneic Hematopoietic Cell Transplantation - an EBMT Inborn Errors Working Party and Scetide Retrospective Analysis
    Albert, Michael H.
    Slatter, Mary
    Gennery, Andrew
    Guengoer, Tayfun
    Blok, Henric-Jan
    Wang, Junfeng
    Courteille, Virginie
    Bernardo, Maria Ester
    Bodova, Ivana
    Bruno, Benedicte
    Bykova, Tatjana A.
    Chiesa, Robert
    Fischer, Alain
    Formankova, Renata
    Kalwak, Krzysztof
    Klein, Christoph
    Kozlovskaya, Svetlana
    Kupesiz, O. Alphan
    Locatelli, Franco
    Mahlaoui, Nizar
    Moshous, Despina
    Neven, Benedicte
    Porta, Fulvio
    Schulz, Ansgar
    Sykora, Karl-Walter
    Unal, Ekrem
    Winiarski, Jacek H.
    Zecca, Marco
    Veys, Paul
    Lankester, Arjan
    BLOOD, 2018, 132
  • [44] Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease
    Claviez, A
    Klingebiel, T
    Beyer, J
    Nürnberger, W
    Ehninger, G
    Suttorp, M
    Dreger, P
    Dörffel, W
    Schmitz, N
    ANNALS OF HEMATOLOGY, 2004, 83 (04) : 237 - 241
  • [45] Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia
    B George
    V Mathews
    R V Shaji
    V Srivastava
    A Srivastava
    M Chandy
    Bone Marrow Transplantation, 2005, 35 : 341 - 343
  • [46] Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia
    George, B
    Mathews, V
    Shaji, RV
    Srivastava, V
    Srivastava, A
    Chandy, M
    BONE MARROW TRANSPLANTATION, 2005, 35 (04) : 341 - 343
  • [47] Second Allogeneic Hematopoietic Cell Transplantation Following Graft Failure in Children
    Yi, Eun Sang
    Ju, Hee Young
    Lee, Ji Won
    Sung, Ki Woong
    Hur, Jin
    Yoo, Keon Hee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2025, 40 (10)
  • [48] Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML
    B Horn
    L-A Baxter-Lowe
    L Englert
    A McMillan
    M Quinn
    K DeSantes
    M Cowan
    Bone Marrow Transplantation, 2006, 37 : 263 - 269
  • [49] A fludarabine-based conditioning regimen for late graft failure (GF) after allogeneic bone marrow transplantation (BMT) in patients with aplastic anemia (AA).
    Kook, H
    Kim, HT
    Cho, SH
    Lee, JJ
    Chung, IJ
    Choi, IS
    Kim, HJ
    Hwang, TJ
    BLOOD, 2002, 100 (11) : 456B - 456B
  • [50] Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML
    Horn, B
    Baxter-Lowe, LA
    Englert, L
    McMillan, A
    Quinn, M
    DeSantes, K
    Cowan, M
    BONE MARROW TRANSPLANTATION, 2006, 37 (03) : 263 - 269
12345